Pancreatic Cancer Research

ResearcherShizuoka General HospitalActive in the last 2 years

Shinya Endo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3045-4735; OpenAlex author ID A5103160687. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 4 papers

Papers 9

  1. Clinical and imaging differences between pancreatic carcinoma in situ and T1a/T1b pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-026-05453-w↗
  2. Intratumoral perforation following endoscopic duodenal stent placement for pancreatic cancer with gastric outlet obstruction. Co-author DOI 10.1007/s12328-026-02311-6↗
  3. Groove area involvement predicts post-ERCP pancreatitis after 8-mm fully-covered metal stent placement in resectable pancreatic cancer. Co-author DOI 10.1055/a-2803-4865↗
  4. Neoadjuvant Chemotherapy after Plasmapheresis in Borderline Resectable Pancreatic Cancer: A Case Report. Co-author DOI 10.1159/000553338↗
  5. Assessment of safety and patency of 7-mm covered metal stents for preoperative biliary drainage in pancreatic cancer: Prospective multicenter study. Co-author DOI 10.1055/a-2503-1995↗
  6. Minor papilla approach improves technical success of nasopancreatic drainage-based pancreatic juice cytology for early pancreatic cancer diagnosis. Co-author DOI 10.1055/a-2631-7957↗
  7. Intratumoral Air Bubbles and Hematemesis As Predictors of Pseudoaneurysm Rupture in Unresected Pancreatic Cancer. Co-author DOI 10.2169/internalmedicine.0856-22↗
  8. [A case of poorly differentiated pancreatic adenocarcinoma with spontaneous regression wherein retrospective rim enhancement findings were important for diagno… Co-author DOI 10.11405/nisshoshi.118.358↗
  9. Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer. Co-author DOI 10.2169/internalmedicine.5449-20↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shinya Kawaguchi · 9 shared papers, 2021–2026 · strength 2.28
  2. Tatsunori Satoh · 7 shared papers, 2023–2026 · strength 1.96
  3. Kazuya Ohno · 4 shared papers, 2025–2026 · strength 1.21
  4. Naofumi Shirane · 5 shared papers, 2021–2026 · strength 1.17
  5. Yuichi Masui · 3 shared papers, 2025–2026 · strength 0.87
  6. Haruna Takahashi · 3 shared papers, 2025–2026 · strength 0.85
  7. Hideyuki Kanemoto · 3 shared papers, 2021–2026 · strength 0.78
  8. Asami Kawai · 2 shared papers, 2025–2026 · strength 0.53
  9. Shuzo Terada · 3 shared papers, 2021–2023 · strength 0.52
  10. Yoshihiro Uehara · 1 shared paper, 2026 · strength 0.36
  11. Fumitaka Niiya · 1 shared paper, 2025 · strength 0.22
  12. Shinya Uemura · 1 shared paper, 2025 · strength 0.22
  13. Keita P. Mori · 1 shared paper, 2025 · strength 0.22
  14. Hirotoshi Ishiwatari · 1 shared paper, 2025 · strength 0.22
  15. Junya Sato · 1 shared paper, 2025 · strength 0.22
  16. Takuji Iwashita · 1 shared paper, 2025 · strength 0.22
  17. Aya Muramatsu · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.